Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  The Lancet

• Publication date

  1988-11-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(88)90812-4PMID 2903955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment.

  1989cited by this paper
• Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive.

  1987cited by this paper
• Fatty acid composition of phospholipids in bile in man: promoting effect of deoxycholate on arachidonate.

  1987cited by this paper
• Gallstone recurrence after medical dissolution. An overestimated threat?

  1986cited by this paper
• Abnormal gallbladder emptying in a subgroup of patients with gallstones.

  1985cited by this paper
• Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying

  1984cited by this paper
• Effect of dietary cholesterol and indomethacin on cholelithiasis and gallbladder motility in guinea pig

  1984cited by this paper
• Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying.

  1984cited by this paper
• Arachidonic acid stimulates mucin secretion in prairie dog gallbladder.

  1983cited by this paper
• High performance liquid chromatographic analysis of molecular species of phosphatidylcholine--development of quantitative assay and its application to human bile.

  1983cited by this paper
• Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism.

  1983cited by this paper
• Is recurrence inevitable after gallstone dissolution by bile-acid treatment?

  1982cited by this paper
• Abnormal gallbladder emptying in patients with gallstones

  1982cited by this paper
• Aspirin prevention of cholesterol gallstone formation in prairie dogs.

  1981cited by this paper
• Cholesterol and bile acid absorption during bile acid therapy in obese subjects undergoing weight reduction.

  1980cited by this paper
• Cholesterol and Bile Acid Absorption During Bile Acid Therapy in Obese Subjects Undergoing Weight Reduction

  1980cited by this paper
• Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?

  1977cited by this paper
• The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients

  1976cited by this paper
• Effects of obesity and caloric intake on biliary lipid metabolism in man.

  1975cited by this paper
• Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.

  1974cited by this paper
• Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis.

  1972cited by this paper
• Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography.

  1970cited by this paper
• Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver

  1969cited by this paper
• Gall Stones in Patients with Disorders of the Terminal Ileum and Disturbed Bile Salt Metabolism*

  1969cited by this paper

• The inflammatory inception of gallbladder cancer.

  2016cites this paper
• Cholesterol gallstone disease: focusing on the role of gallbladder

  2015cites this paper
• Bile acids regulate colonic epithelial barrier function: implications for pathogenesis and therapy of inflammatory bowel disease

  2015cites this paper
• Aetiological and clinical aspects of symptomatic gallstone disease and pancreatic cancer.

  2011cites this paper
• Gallstones and Benign Biliary Diseases

  2011cites this paper
• Pathogenesis of gallstones.

  2010cites this paper
• Análise dos lipídios biliares no cálculo e na bile em portadores brasileiros de litíase biliar

  2010cites this paper
• Gallstone disease : Population based studies on risk factors, symptomatology and complications

  2008cites this paper
• Non-surgical options for the management of gallstone disease: an overview

  2006cites this paper
• bladder: inhibition by aspirin

  2006cites this paper
• Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China

  2005cites this paper
• Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans

  2005cites this paper
• Gallstone Disease after Extended (D2) Lymph Node Dissection for Gastric Cancer

  2005cites this paper
• Gallbladder mucin plays a role in gallstone formation.

  2004cites this paper
• Comparison of the effect of diclofenac with hyoscine‐N‐butylbromide in the symptomatic treatment of acute biliary colic

  2004cites this paper
• Indomethacin decreases viscosity of gallbladder bile in patients with cholesterol gallstone disease

  2004cites this paper
• Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic.

  2002cites this paper
• Role of biliary proteins and non-protein factors in kinetics of cholesterol crystallisation and gallstone growth.

  2001cites this paper
• Cholelithiasic Disease and Associated Factors in a Spanish Population

  2001cites this paper
• Antidenaturant drugs for cataract and other condensation diseases.

  2001cites this paper
• Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy.

  2000cites this paper
• Multiseptate gallbladder with cholelithiasis diagnosed incidentially in an elderly patient.

  2000cites this paper
• Postprandial refilling and turnover: specific gallbladder motor function defects in patients with gallstone recurrence

  2000cites this paper
• Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.

  2000cites this paper
• Gallstones in patients with rheumatoid arthritis.

  1999cites this paper
• Beneficial effects of NSAIDs in the gastrointestinal tract.

  1999cites this paper
• Pigment gallstones in Crohn's disease.

  1999cites this paper
• Pathogenesis of gallstones in Crohn's disease

  1999cites this paper
• REVERSAL OF GASTRIC ATROPHY AFTER HELICOBACTER PYLORI ERADICATION: IS IT POSSIBLE OR NOT?

  1998cites this paper
• NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND GALLSTONE DISEASE: WILL AN ASPIRIN A DAY KEEP THE GALLSTONES AWAY?

  1998cites this paper
• Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study

  1998cites this paper
• Prevalence of gallstone disease in a Swedish population sample. Relations to occupation, childbirth, health status, life style, medications, and blood lipids.

  1998cites this paper
• Ground squirrel model for cholelithiasis: Role of epithelial glycoproteins

  1997cites this paper
• Factors associated with gallstone disease in the MICOL experience

  1997cites this paper
• Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.

  1996cites this paper
• The choleretic effect of nonsteroidal anti-inflammatory drugs in total parenteral nutrition-associated cholestasis.

  1996cites this paper
• Prevention of gastrointestinal diseases.

  1996cites this paper
• Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock‐wave lithotripsy

  1996cites this paper
• Effect of NSAIDs on gallbladder bile composition

  1995cites this paper
• Effect of cisapride on gallbladder motility after extracorporeal lithotripsy shock-wave

  1995cites this paper
• Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management.

  1995cites this paper
• Continuous Versus Intermittent Subcutaneous Infusion of Octreotide in the Treatment of Acromegaly

  1995cites this paper
• Effect of aspirin on gallbladder motility in patients with gallstone disease

  1995cites this paper
• Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect.

  1995cites this paper
• Effect of cisapride on gallbladder motility after extracorporeal shock-wave lithotripsy.

  1995cites this paper
• Pharmacological Treatment of Gallstones

  1994cites this paper
• Recurrence of gallstones following nonsurgical therapy with extracorporeal shock-wave lithotripsy.

  1994cites this paper
• Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy?

  1994cites this paper
• Effect of nicotine on gallbladder bile

  1994cites this paper
• Endogenous hypercholecystokininemia, but not aspirin, reduces the gallstone incidence in the hamster model.

  1994cites this paper
• Pharmacological treatment of gallstones. Practical guidelines.

  1994cites this paper
• Conséquences hépatiques et biliaires de la nutrition artificielle

  1994cites this paper
• Biosynthesis of a human gall-bladder mucin.

  1994cites this paper
• Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?

  1994cites this paper
• [Is there still a place for non surgical treatments of cholelithiasis?].

  1994cites this paper
• Effect of non-steroidal anti-inflammatory drugs on formation of gallbladder stones.

  1994cites this paper
• Incidence and prevention of gallbladder stones after non-operative treatment.

  1994cites this paper
• Gallstone recurrence after shock wave therapy.

  1993cites this paper
• Mucus synthesis by the human gall bladder.

  1993cites this paper
• Gall stones and gall bladder motility.

  1993cites this paper
• Recurrent gallstone formation after successful extracorporeal shock-wave lithotripsy.

  1993cites this paper
• Gallstones during octreotide therapy.

  1993cites this paper
• Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

  1993cites this paper
• Managing gallbladder disease with prostaglandin inhibitors.

  1993cites this paper
• Injection sclerotherapy in portal hypertension.

  1993cites this paper
• Future directions for conservative treatment of gallbladder calculi

  1993cites this paper
• Cholecystolithiasis: Lithotherapy for the 1990s

  1992cites this paper
• Gallstones during octreotide therapy.

  1992cites this paper
• Octreotide in the Treatment of Disorders of the Gastrointestinal System

  1992cites this paper
• Nonsteroidal anti-inflammatory drugs and gallstone formation

  1992cites this paper
• Cholesterol gallstones and aspirin.

  1992cites this paper
• Indomethacin and postprandial gallbladder emptying.

  1992cites this paper
• Risk factors for gallstone formation in young Saudi women: A case control study.

  1992cites this paper
• Gallstone disease. Pathophysiology, epidemiology, natural history, and treatment options.

  1992cites this paper
• Therapeutic approaches to the problem of biliary sludge and gallstone formation during total parenteral nutrition.

  1992cites this paper
• Gallstone-dissolving agents.

  1992cites this paper
• Management of recurrent gallstones.

  1992cites this paper
• Mucus glycoprotein biosynthesis in the human gall bladder: inhibition by aspirin.

  1992cites this paper
• Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.

  1992cites this paper
• Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans

  1992cites this paper
• Mucin-type glycoproteins.

  1992cites this paper
• New trends in gallstone management

  1991cites this paper
• Dissolution of cholesterol gall stones using methyltertbutyl ether: a safe effective treatment.

  1991cites this paper
• One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease

  1991cites this paper
• Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin hypersecretion in the cholesterol-fed prairie dog.

  1991cites this paper
• [Prevention of recurrence after successful gallstone dissolution].

  1991cites this paper
• Gallbladder stones: management.

  1991cites this paper
• Lessons from experimental cholelithiasis: gallbladder and mucosa, nonsteroidal antiinflammatory drugs, and gallstones.

  1991cites this paper
• Symptomatic gallstones--a disease of non-smokers?

  1991cites this paper
• Prediction of organ system toxicity with antirheumatic drug therapy

  1991cites this paper
• Percutaneous Approach to Gallbladder Disease

  1991cites this paper
• Gallstone recurrence after oral bile acid dissolution treatment.

  1990cites this paper
• Gallstone Prevention After Successful Treatment

  1990cites this paper
• Gallbladder mucin as a pronucleating agent for cholesterol monohydrate crystals in bile.

  1990cites this paper
• Pathogenesis of gallstones: implications for management.

  1990cites this paper
• Restraint urged for biliary lithotripsy

  1990cites this paper
• Interactions between gall bladder bile and mucosa; relevance to gall stone formation.

  1990cites this paper
• Biliary lithotripsy.

  1990cites this paper
• Principles of Gallstone Dissolution with Chenodeoxycholic Acid, Ursodeoxycholic Acid, and the Combination of both Bile Acids

  1990cites this paper
• Pathophysiology and Pathogenesis of Cholesterol Gallstone Formation

  1990cites this paper